vimarsana.com

Page 2 - Pascal Prigent News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GENFIT to Present Latest ACLF Research at EASL Congress™

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 29, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage.

France generalUnited statesUnited kingdomStephanie boyerDonnar cryerRichard moreauPascal prigentEuropean liver patient associationGlobal liver instituteExchange commissionChronic liver failureEuropean foundationLatin americaDean humChief scientific officerPoster cirrhosis

GENFIT : Shareholders Letter 16 - May 2024

GENFIT : Shareholders Letter 16 - May 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomProfesseur laguesseMadrigal rezdiffraPascal prigentGlobal liver instituteExchange commissionFaculty of pharmaceutical sciences in lilleDrug administrationProducts regulatory agencyUncertainties of the companyPharmaceutical sciencesPrimary biliary cholangitisChronic liver failureFranchise enrichedNew england journal

GENFIT : Extra-Financial Performance Report 2024, 2023 Activity

Extra-Financial Performance Report 2024 2023 Activity .

United statesJean christophe marcouxPascal prigentCatherine larueSustainable development goal healthCompany raisonCorporate affairsCompany versantisSustainable development goals oddsInternational frameworksExchange commissionUncertainties of the companyCommittee of the board directorsSustainable development goalsExtra financial performance reportSocietal policies

GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023)

Lille , Cambridge , Zurich , April 25, 2024 - GENFIT , a late-stage biopharmaceutical company committed to improving the lives of patients with rare, life-threatening liver diseases, today announced.

United kingdomFrance generalUnited statesLes entreprisesPascal prigentEuronext corporate servicesExchange commissionSustainable development goal of the united nationsFinancial performance reportExtra financial performanceChief executive officerEuropean corporate sustainabilitySustainable finance disclosure regulationSustainable development goalAcute on chronic liver failurePrimary biliary cholangitis

GENFIT: Publication of the 2024 Extra-Financial Performance

Lille (France), Cambridge (Massachusetts, USA), Zurich (Switzerland), April 25, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical.

France generalUnited statesUnited kingdomPascal prigentLes entreprisesEuronext corporate servicesSustainable development goal of the united nationsExchange commissionFinancial performance reportExtra financial performanceChief executive officerEuropean corporate sustainabilitySustainable finance disclosure regulationSustainable development goalAcute on chronic liver failurePrimary biliary cholangitis

vimarsana © 2020. All Rights Reserved.